Although it is of course important to check efficacy on a regular basis, I honestly dont feel the need to conduct any further experiments on either supplement, basically because I really do notice the difference if I stop taking them and I dont like that difference
Fujita, K
This modulatory capacity allows BPC-157 to correct both hypo- and hypermotility conditions
[DOI] [PubMed] [Google Scholar] 143.Nashiro K, Guevara-Aguirre J, Braskie MN, Hafzalla GW, Velasco R, Balasubramanian P, Wei M, Thompson PM, Mather M, Nelson MD, Guevara A, Teran E, and Longo VD
sequence identity: 27%) also contains an NLL region, but its interaction with the adenine phosphate of NADPH differs significantly from that of Pa DHDPR (Fig